> top > docs > PMC:1420271 > spans > 10914-11052 > annotations

PMC:1420271 / 10914-11052 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T6153 1-5 PR:000006847 denotes ESG1
T6154 60-86 PR:000009799 denotes leukemia inhibitory factor
T6155 102-115 CHEBI:26536 denotes retinoic acid

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T6292 1-5 PR_EXT:000006847 denotes ESG1
T6293 5-6 SO_EXT:sequence_nullness_or_absence denotes -
T6294 7-8 SO_EXT:sequence_nullness_or_absence denotes -
T6295 9-14 CL_GO_EXT:cell denotes cells
T6296 15-29 GO_PATO_RO_EXT:developmental_differentiation_process_or_quality denotes differentiated
T6297 60-86 PR_EXT:000009799 denotes leukemia inhibitory factor
T6298 102-115 CHEBI:26536 denotes retinoic acid

craft-sa-dev

Id Subject Object Predicate Lexical cue
T6738 88-94 NN denotes Figure
T6739 97-98 -RRB- denotes )
T6740 99-101 CC denotes or
T6741 102-110 JJ denotes retinoic
T6742 116-125 NN denotes treatment
T6743 111-115 NN denotes acid
T6744 126-127 -LRB- denotes (
T6745 131-136 VBN denotes shown
T6746 127-130 RB denotes not
T6747 136-137 -RRB- denotes )
T6748 137-138 . denotes .
T6729 39-44 IN denotes after
T6730 45-48 DT denotes the
T6731 49-56 NN denotes removal
T6732 57-59 IN denotes of
T6733 60-68 NN denotes leukemia
T6734 80-86 NN denotes factor
T6735 69-79 JJ denotes inhibitory
T6736 87-88 -LRB- denotes (
T6737 95-97 NN denotes 5B
T6721 0-138 sentence denotes ESG1-/- cells differentiated normally after the removal of leukemia inhibitory factor (Figure 5B) or retinoic acid treatment (not shown).
T6722 1-5 NN denotes ESG1
T6723 9-14 NNS denotes cells
T6724 5-6 SYM denotes -
T6725 6-7 HYPH denotes /
T6726 7-8 SYM denotes -
T6727 15-29 VBD denotes differentiated
T6728 30-38 RB denotes normally
R1567 T6722 T6723 nmod ESG1,cells
R1568 T6723 T6727 nsubj cells,differentiated
R1569 T6724 T6722 punct -,ESG1
R1570 T6725 T6722 punct /,ESG1
R1571 T6726 T6722 punct -,ESG1
R1572 T6728 T6727 advmod normally,differentiated
R1573 T6729 T6727 prep after,differentiated
R1574 T6730 T6731 det the,removal
R1575 T6731 T6729 pobj removal,after
R1576 T6732 T6731 prep of,removal
R1577 T6733 T6734 nmod leukemia,factor
R1578 T6734 T6732 pobj factor,of
R1579 T6735 T6734 amod inhibitory,factor
R1580 T6736 T6737 punct (,5B
R1581 T6737 T6734 parataxis 5B,factor
R1582 T6738 T6737 compound Figure,5B
R1583 T6739 T6737 punct ),5B
R1584 T6740 T6731 cc or,removal
R1585 T6741 T6742 amod retinoic,treatment
R1586 T6742 T6731 conj treatment,removal
R1587 T6743 T6742 compound acid,treatment
R1588 T6744 T6745 punct (,shown
R1589 T6745 T6742 parataxis shown,treatment
R1590 T6746 T6745 neg not,shown
R1591 T6747 T6745 punct ),shown
R1592 T6748 T6727 punct .,differentiated